
浏览全部资源
扫码关注微信
430074 武汉,武汉大学附属同仁医院(武汉市第三医院)消化内科
[陈巍,E-mail:hpdlx9009@163.com CHEN Wei, E-mail: hpdlx9009@163.com
收稿:2021-11-28,
修回:2022-03-01,
纸质出版:2022-07-15
移动端阅览
黄莎莎, 邹艳丽, 谭洁, 等. CX3CR1沉默介导的巨噬细胞极化减轻CCl4诱导的小鼠肝纤维化[J]. 陆军军医大学学报, 2022,44(13):1314-1321.
Shasha HUANG, Yanli ZOU, Jie TAN, et al. CX3CR1 silencing-mediated macrophage polarization attenuates CCl4 -induced liver fibrosis in mice[J]. Journal of Army Medical University, 2022, 44(13): 1314-1321.
黄莎莎, 邹艳丽, 谭洁, 等. CX3CR1沉默介导的巨噬细胞极化减轻CCl4诱导的小鼠肝纤维化[J]. 陆军军医大学学报, 2022,44(13):1314-1321. DOI: 10.16016/j.2097-0927.202111205.
Shasha HUANG, Yanli ZOU, Jie TAN, et al. CX3CR1 silencing-mediated macrophage polarization attenuates CCl4 -induced liver fibrosis in mice[J]. Journal of Army Medical University, 2022, 44(13): 1314-1321. DOI: 10.16016/j.2097-0927.202111205.
目的
2
探讨CX3CR1在CCl
4
诱导的小鼠肝纤维化中的作用。
方法
2
将小鼠分为正常组(
n
=24)、CCl
4
组(
n
=36)、CCl
4
+sh-NC组(
n
=36)、CCl
4
+sh-CX3CR1组(
n
=36)。除正常组外,其余组通过腹腔注射CCl
4
诱导肝纤维化。从CCl
4
诱导的肝纤维化4周开始,每周分别向CCl
4
+sh-NC组和CCl
4
+sh-CX3CR1组小鼠尾静脉注射sh-NC或sh-CX3CR1,持续2周。通过免疫组织化学确定小鼠肝脏组织中CX3CR1的表达情况,免疫荧光染色分析肝脏组织中M1-巨噬细胞(F4/80
+
iNOS
+
)或M2-巨噬细胞(F4/80
+
CD206
+
)表达。ELISA试剂盒法检测小鼠血清IL-1β、IL-6和TGF-β1水平。使用流式细胞仪测定原代肝脏巨噬细胞与活化HSC共培养后巨噬细胞M1和M2表型变化。
结果
2
在健康的非纤维化对照肝脏中几乎检测不到CX3CR1,而在CCl
4
处理4周和6周后,CX3CR1强烈上调。通过沉默CCl
4
小鼠CX3CR1表达,小鼠肝炎症细胞募集和纤维组织沉积化的严重程度均明显减轻,并且α-SMA、N-cadherin和Vimentin的蛋白水平降低,E-cadherin的蛋白表达增加。与CCl
4
+sh-NC组相比,CCl
4
+sh-CX3CR1组小鼠血清IL-1β、IL-6和TGF-β1水平均下调4.6~8.1倍(
P
<
0.01),且M2-巨噬细胞的百分率和M2/M1比值均显著增加(
P
<
0.01)。在用CX3CR1沉默的小鼠肝星状细胞和巨噬细胞的共培养中,高M2/M1-巨噬细胞比值抑制胶原的产生。
结论
2
CX3CR1沉默通过促进M1向M2-巨噬细胞的极化发挥抗肝纤维化作用。
Objective
2
To investigate the role of CX3CR1 in liver fibrosis induced by CCl
4
in mice.
Methods
2
The mice were divided into normal group (
n
=24)
CCl
4
group (
n
=36)
CCl
4
+sh-NC group (
n
=36)
and CCl
4
+sh-CX3CR1 group (
n
=36)
and all the groups were induced liver fibrosis by intraperitoneal injection of CCl
4
except the normal group. From the 4th week of CCl
4
injection
the mice of CCl
4
+sh-NC group and CCl
4
+sh-CX3CR1 group were respectively injected with shRNA or shRNA-CX3CR1 by tail vein weekly
for 2 weeks. The expression of CX3CR1 in the liver tissues was determined by immunohistochemistry
and the number of M1 macrophages (F4/80
+
iNOS
+
) or M2 macrophages (F4/80
+
CD206
+
) in the liver tissues was measured by immunofluorescence staining. ELISA was used to detect the serum levels of IL-1β
IL-6 and TGF-β1 in mice
and flow cytometry was adopted to analyze the phenotypic changes of M1 and M2 macrophages after co-culture of primary liver macrophages with activated hepatic stellate cells (HSC).
Results
2
CX3CR1 was hardly detected in healthy non-fibrotic control livers
but strongly up-regulated 4~6 weeks after CCl
4
treatment. By silencing CX3CR1 expression in CCl
4
-induced liver fibrosis mice
the severity of inflammatory cell recruitment and fibrous tissue deposition in liver tissues was significantly reduced
and the protein levels of α-SMA
N-cadherin and Vimentin were decreased
while the expression of E-cadherin increased. As compared with the CCl
4
+sh-NC group
the serum levels of IL-1β
IL-6 and TGF-β1 were down-regulated by 4.6-8.1 times in the CCl
4
+sh-CX3CR1 group (
P
<
0.01)
and the percentage of M2-macrophages as well as the M2/M1 ratio were remarkably elevated (
P
<
0.01). In the co-cultures of HSC and macrophages extracted from CX3CR1 silencing mice
collagen production was inhibited due to the high M2/M1 ratio.
Conclusion
2
CX3CR1 silencing plays an anti-hepatic fibrosis role by promoting polarization of M1 to M2 macrophage.
孙鑫, 黄恺, 张满, 等. HBV-Tg复合四氯化碳模型小鼠肝内淋巴细胞亚群变化特点及其与HBV病毒学和肝纤维化的相关性分析[J]. 中华肝脏病杂志, 2020, 28(7): 580-585. DOI: 10.3760/cma.j.cn501113-20190723-00265.
SUN X, HUANG K, ZHANG M, et al . Correlational analysis of alternation of clinical features of intrahepatic lymphocyte subsets with HBV virology and liver fibrosis in HBV-Tg composite CCl 4 mice model[J ] . Chin J Hepatol, 2020, 28(7): 580-585. DOI: 10.3760/cma.j.cn501113-20190723-00265..
王煜, 马娟, 张旭, 等. 慢性乙型肝炎患者STING表达与病毒载量及肝组织病理的相关性[J]. 中华医院感染学杂志, 2020, 30(1): 82-85. DOI: 10.11816/cn.ni.2020-190059.
WANG Y, MA J, ZHANG X, et al . Correlation between expression of STING and viral load and liver histopathology of patients with chronic hepatitis B[J ] . Chin J Nosocomiol, 2020, 30(1): 82-85. DOI: 10.11816/cn.ni.2020-190059.
XU X Y, DU Y, LIU X, et al . Targeting Follistatin like 1 ameliorates liver fibrosis induced by carbon tetrachloride through TGF-β1-miR29a in mice[J ] . Cell Commun Signal, 2020, 18(1): 151. DOI: 10.1186/s12964-020-00610-0.
KISSELEVA T, BRENNER D. Molecular and cellular mechanisms of liver fibrosis and its regression[J]. Nat Rev Gastroenterol Hepatol, 2021, 18(3): 151-166. DOI: 10.1038/s41575-020-00372-7.
KRENKEL O, TACKE F. Liver macrophages in tissue homeostasis and disease[J]. Nat Rev Immunol, 2017, 17(5): 306-321. DOI: 10.1038/nri.2017.11.
伊宏煜, 张津睿, 胡海峰, 等. 乙型肝炎病毒及其核心抗原对巨噬细胞极化的影响[J]. 中国免疫学杂志, 2020, 36(7): 769-773.
YI H Y, ZHANG J R, HU H F, et al . Effect of hepatitis B virus and hepatitis B core antigen on macrophage polarization[J ] . Chin J Immunol, 2020, 36(7): 769-773.
ENGEL D R, KRAUSE T A, SNELGROVE S L, et al . CX3CR1 reduces kidney fibrosis by inhibiting local proliferation of profibrotic macrophages[J ] . J Immunol, 2015, 194(4): 1628-1638. DOI: 10.4049/jimmunol.1402149.
CHEN Y Q, ZHANG H, LI F, et al . Inhibition of CX3C receptor 1-mediated autophagy in macrophages alleviates pulmonary fibrosis in hyperoxic lung injury[J ] . Life Sci, 2020, 259: 118286. DOI: 10.1016/j.lfs.2020.118286.
ISHIDA Y, KIMURA A, NOSAKA M, et al . Essential involvement of the CX3CL1-CX3CR1 axis in bleomycin-induced pulmonary fibrosis via regulation of fibrocyte and M2 macrophage migration[J ] . Sci Rep, 2017, 7(1): 16833. DOI: 10.1038/s41598-017-17007-8..
BEKKI Y, YOSHIZUMI T, SHIMODA S, et al . Hepatic stellate cells secreting WFA +-M2BP: its role in biological interactions with Kupffer cells[J ] . J Gastroenterol Hepatol, 2017, 32(7): 1387-1393. DOI: 10.1111/jgh.13708.
刘新, 娄金丽, 白丽, 等. 小鼠肝纤维化形成过程中肝内巨噬细胞的表型转换[J]. 标记免疫分析与临床, 2019, 26(9): 1532-1536, 1564. DOI: 10.11748/bjmy.issn.1006-1703.2019.09.020.
LIU X, LOU J L, BAI L, et al . Phenotypes of macrophages conversion in liver during the development of liver fibrosis of mice[J ] . Labeled Immunoass Clin Med, 2019, 26(9): 1532-1536, 1564. DOI: 10.11748/bjmy.issn.1006-1703.2019.09.020.
唐颖悦, 李静, 雷晓红, 等. CCl4诱导肝纤维化小鼠模型中肝脏巨噬细胞及淋巴细胞亚群变化的初步分析[J]. 肝脏, 2019, 24(4): 377-381. DOI: 10.14000/j.cnki.issn.1008-1704.2019.04.014.
TANG Y Y, LI J, LEI X H, et al . Preliminary analysis of changes of hepatic macrophages and lymphocyte subsets in CCl 4 -induced hepatic fibrosis in mice[J ] . Chin Hepatol, 2019, 24(4): 377-381. DOI: 10.14000/j.cnki.issn.1008-1704.2019.04.014..
JULIA V, STAUMONT-SALLE D, DOMBROWICZ D. Role of fractalkine/CX3CL1 and its receptor CX3CR1 in allergic diseases[J]. Med Sci (Paris), 2016, 32(3): 260-266. DOI: 10.1051/medsci/20163203010.
刘莹, 刁波, 王刚, 等. 大鼠肝纤维化进程中原代Kupffer细胞吞噬能力及表型变化特征研究[J]. 免疫学杂志, 2019, 35(3): 213-218. DOI: 10.13431/j.cnki.immunol.j.20190034.
LIU Y, DIAO B, WANG G, et al . The phagocytic ability and phenotypic changes of primary Kupffer cells in rat liver fibrosis[J ] . Immunol J, 2019, 35(3): 213-218. DOI: 10.13431/j.cnki.immunol.j.20190034.
MA P F, GAO C C, YI J, et al . Cytotherapy with M1-polarized macrophages ameliorates liver fibrosis by modulating immune microenvironment in mice[J ] . J Hepatol, 2017, 67(4): 770-779. DOI: 10.1016/j.jhep.2017.05.022.
谭海鹏. 巨噬细胞对凋亡细胞的清除及炎症调控作用[J]. 复旦学报(医学版), 2020, 47(6): 911-916. DOI: 10.3969/j.issn.1672-8467.2020.06.018.
TAN H P. Clearance of apoptotic cells by macrophages and resolution of inflammation[J]. Fudan Univ J Med Sci, 2020, 47(6): 911-916. DOI: 10.3969/j.issn.1672-8467.2020.06.018.
WAN J H, BENKDANE M, TEIXEIRA-CLERC F, et al . M2 Kupffer cells promote M1 Kupffer cell apoptosis: a protective mechanism against alcoholic and nonalcoholic fatty liver disease[J ] . Hepatology, 2014, 59(1): 130-142. DOI: 10.1002/hep.26607.
LI L, WEI W, LI Z Z, et al . The spleen promotes the secretion of CCL2 and supports an M1 dominant phenotype in hepatic macrophages duri ng liver fibrosis[J ] . Cell Physiol Biochem, 2018, 51(2): 557-574. DOI: 10.1159/000495276.
SCHUPPAN D, SURABATTULA R, WANG X Y. Determinants of fibrosis progression and regression in NASH[J]. J Hepatol, 2018, 68(2): 238-250. DOI: 10.1016/j.jhep.2017.11.012.
DOU Y, SHEN H T, FENG D X, et al . Tumor necrosis factor receptor-associated factor 6 participates in early brain injury after subarachnoid hemorrhage in rats through inhibiting autophagy and promoting oxidative stress[J ] . J Neurochem, 2017, 142(3): 478-492. DOI:10.1111/jnc.14075.
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621